Systematic review with meta-analysis: do interferon lambda 3 polymorphisms predict the outcome of interferon-therapy in hepatitis B infection?
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Systematic review with meta-analysis: do interferon lambda 3 polymorphisms predict the outcome of interferon-therapy in hepatitis B infection?
Authors
Keywords
-
Journal
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Volume 39, Issue 6, Pages 569-578
Publisher
Wiley
Online
2014-01-27
DOI
10.1111/apt.12631
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection
- (2015) JOURNAL OF HEPATOLOGY
- HLA-DP and IL28B Polymorphisms: Influence of Host Genome on Hepatitis B Surface Antigen Seroclearance in Chronic Hepatitis B
- (2013) Wai-Kay Seto et al. CLINICAL INFECTIOUS DISEASES
- IL28Bgenotype is not useful for predicting treatment outcome in Asian chronic hepatitis B patients treated with pegylated interferon-α
- (2013) Jacinta A Holmes et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- 737 POLYMORPHISMS NEAR THE IL28B GENE ARE NOT ASSOCIATED WITH RESPONSE TO PEGINTERFERON IN HBeAg-NEGATIVE CHRONIC HEPATITIS B PATIENTS
- (2013) W.P. Brouwer et al. JOURNAL OF HEPATOLOGY
- Host Genetic Factors Affecting Spontaneous HBsAg Seroclearance in Chronic Hepatitis B Patients
- (2013) Huei-Ru Cheng et al. PLoS One
- Association of the rs3077 and rs9277535 polymorphisms inHLA-DPwith hepatitis B virus infection and spontaneous clearance: A meta-analysis
- (2013) Xiao-Lin Zhang et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Chronic Hepatitis B Infection
- (2012) Alexander Kuo et al. Clinics in Liver Disease
- Randomised study comparing 48 and 96 weeks peginterferon α-2a therapy in genotype D HBeAg-negative chronic hepatitis B
- (2012) Pietro Lampertico et al. GUT
- IL28B polymorphisms predict interferon-related hepatitis B surface antigen seroclearance in genotype D hepatitis B e antigen-negative patients with chronic hepatitis B
- (2012) Pietro Lampertico et al. HEPATOLOGY
- Combined effects of different interleukin-28B gene variants on the outcome of dual combination therapy in chronic hepatitis C virus type 1 infection
- (2012) Janett Fischer et al. HEPATOLOGY
- Unknown
- (2012) Pietro Lampertico et al. HEPATOLOGY
- Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update
- (2012) Yun-Fan Liaw et al. Hepatology International
- Relationship between HLA-DP gene polymorphisms and clearance of chronic hepatitis B virus infections: Case–control study and meta-analysis
- (2012) Zehui Yan et al. INFECTION GENETICS AND EVOLUTION
- Genome-Wide Association Study Confirming Association of HLA-DP with Protection against Chronic Hepatitis B and Viral Clearance in Japanese and Korean
- (2012) Nao Nishida et al. PLoS One
- Genetic variation in IL28B and treatment outcome in HBeAg-positive and -negative chronic hepatitis B patients treated with Peg interferon alfa-2a and adefovir
- (2012) A. de Niet et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Evaluation of susceptibility locus for response to interferon-α based therapy in chronic hepatitis B patients in Chinese
- (2011) Xiaopan Wu et al. ANTIVIRAL RESEARCH
- Effect of host and viral factors on hepatitis B e antigen-positive chronic hepatitis B patients receiving pegylated interferon-α-2a therapy
- (2011) Tai-Chung Tseng et al. ANTIVIRAL THERAPY
- Antiviral drugs for HBV liver disease
- (2011) Mauro Viganò et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Polymorphisms Near IL28B and Serologic Response to Peginterferon in HBeAg-Positive Patients With Chronic Hepatitis B
- (2011) Milan J. Sonneveld et al. GASTROENTEROLOGY
- Association of HLA and TNF polymorphisms with the outcome of HBV infection in the South Indian population
- (2011) G J Fletcher et al. GENES AND IMMUNITY
- Shorter durations and lower doses of peginterferon alfa-2a are associated with inferior hepatitis B e antigen seroconversion rates in hepatitis B virus genotypes B or C
- (2011) Y.-F. Liaw et al. HEPATOLOGY
- A genome-wide association study of chronic hepatitis B identified novel risk locus in a Japanese population
- (2011) Hamdi Mbarek et al. HUMAN MOLECULAR GENETICS
- 1331 LACK OF ASSOCIATION BETWEEN IL28B VARIANTS AND HBSAG CLEARANCE AFTER INTERFERON TREATMENT
- (2011) A. Mangia et al. JOURNAL OF HEPATOLOGY
- A Common HLA–DPA1 Variant is a Major Determinant of Hepatitis B Virus Clearance in Han Chinese
- (2011) Ping An et al. JOURNAL OF INFECTIOUS DISEASES
- Evaluation of Genetic Susceptibility Loci for Chronic Hepatitis B in Chinese: Two Independent Case-Control Studies
- (2011) Li Wang et al. PLoS One
- Associations of HLA-DP Variants with Hepatitis B Virus Infection in Southern and Northern Han Chinese Populations: A Multicenter Case-Control Study
- (2011) Jin Li et al. PLoS One
- A Genome-Wide Association Study with DNA Pooling Identifies the Variant rs11866328 in the GRIN2A Gene That Affects Disease Progression of Chronic HBV Infection
- (2011) Lifeng Liu et al. VIRAL IMMUNOLOGY
- Genetic Variation in IL28B Is Associated With Chronic Hepatitis C and Treatment Failure: A Genome-Wide Association Study
- (2010) Andri Rauch et al. GASTROENTEROLOGY
- Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
- (2009) Dongliang Ge et al. NATURE
- Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
- (2009) David L. Thomas et al. NATURE
- IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy
- (2009) Vijayaprakash Suppiah et al. NATURE GENETICS
- Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C
- (2009) Yasuhito Tanaka et al. NATURE GENETICS
- A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians
- (2009) Yoichiro Kamatani et al. NATURE GENETICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More